Security readout for executives and security teams
Plain-English summary
CVE-2020-14506 is a low-severity issue in Philips Clinical Collaboration Platform 12.2.1 and earlier. The product may process input without adequate validation, creating a cross-site request forgery-related risk. The documented impact is limited confidentiality and integrity loss, with no availability impact shown in the supplied CVSS data.
Executive priority
Low priority unless the organization operates affected Philips Clinical Collaboration Platform versions in sensitive clinical workflows. Confirm exposure, follow Philips remediation guidance, and keep the issue on normal vulnerability management timelines.
Technical view
The CVE maps to CWE-352 and is scored CVSS 3.1: 3.4 low. The vector indicates local attack requirements, low complexity, high privileges, no user interaction, unchanged scope, and low confidentiality and integrity impact. The source bundle does not provide exploit details, proof-of-concept status, or a specific fix version.
Likely exposure
Exposure appears limited to organizations running Philips Clinical Collaboration Platform version 12.2.1 or earlier. The supplied affected data does not include CPEs and marks default status as unaffected, so asset validation should rely on product inventory and Philips guidance.
Exploitation context
The source bundle does not identify active exploitation, and the CVE is not listed as CISA KEV. No public exploit status is provided. Treat this as a validation and remediation tracking item rather than an emergency incident unless local exposure is confirmed.
Researcher notes
Evidence is limited to CVE metadata and referenced CISA/Philips advisories in the supplied bundle. The CVSS vector and CSRF title are unusual together, so avoid assumptions about exploit mechanics. No exploit, patch version, or active exploitation evidence is provided.
Mitigation direction
- Identify any Philips Clinical Collaboration Platform deployments and record exact versions.
- Review Philips advisory or support guidance for vendor-recommended remediation.
- Prioritize update or compensating controls for versions 12.2.1 and earlier.
- Restrict platform access to trusted clinical and administrative networks.
- Monitor administrative or configuration changes for unexpected activity.
Validation and detection
- Confirm whether Clinical Collaboration Platform is deployed in the environment.
- Verify whether any instance is version 12.2.1 or earlier.
- Check Philips advisory records for applicable remediation guidance.
- Review access paths to the platform from user workstations and networks.
- Document whether compensating controls reduce unauthorized request risk.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-352: User-session and phishing behavior lookup
Client-side and session-facing weaknesses should be reviewed alongside initial-access and user-execution behaviors. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2020-14506 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Low
- CVSS
- 3.4 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:N
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:N0.82.5Primary CVE scoreVulnerability scoring details
Base CVSS 3.1 score
3.4LowVector: CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:N
Source materials
- CVE List V5 sourceCVE List V5
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01CVE reference · x_refsource_MISC
- https://www.philips.com/a-w/security/security-advisories/product-security-2020.html#2020_archiveCVE reference
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Cross-Site Request Forgery (CSRF)
Cross-Site Request Forgery (CSRF) represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.